Immunopathology of rsv: An updated review

Harrison C. Bergeron; Ralph A. Tripp

doi:10.3390/v13122478

Immunopathology of rsv: An updated review

Harrison C. Bergeron, Ralph A. Tripp

Research output: Contribution to journal › Review article › peer-review

77 Citations (Scopus)

121 Downloads (Pure)

Abstract

RSV is a leading cause of respiratory tract disease in infants and the elderly. RSV has limited therapeutic interventions and no FDA-approved vaccine. Gaps in our understanding of virus–host interactions and immunity contribute to the lack of biological countermeasures. This review updates the current understanding of RSV immunity and immunopathology with a focus on interferon responses, animal modeling, and correlates of protection.

Original language	English
Article number	2478
Pages (from-to)	1-30
Number of pages	30
Journal	Viruses
Volume	13
Issue number	12
DOIs	https://doi.org/10.3390/v13122478
Publication status	Published - Dec 2021
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3390/v13122478Licence: CC BY

ArticleFinal published version, 545 KBLicence: CC BY

Cite this

@article{0dccea058df540b9bd914040a20f9c60,

title = "Immunopathology of rsv: An updated review",

abstract = "RSV is a leading cause of respiratory tract disease in infants and the elderly. RSV has limited therapeutic interventions and no FDA-approved vaccine. Gaps in our understanding of virus–host interactions and immunity contribute to the lack of biological countermeasures. This review updates the current understanding of RSV immunity and immunopathology with a focus on interferon responses, animal modeling, and correlates of protection.",

keywords = "Host–pathogen interaction, Immunity, Immunopathology, Respiratory syncytial virus, RSV",

author = "Bergeron, {Harrison C.} and Tripp, {Ralph A.}",

note = "Funding Information: Funding: This research was funded by the Tripp laboratory, and supported by the Georgia Research Alliance (GRA). Publisher Copyright: {\textcopyright} 2021 by the authors. Licensee MDPI, Basel, Switzerland.",

year = "2021",

month = dec,

doi = "10.3390/v13122478",

language = "English",

volume = "13",

pages = "1--30",

journal = "Viruses",

issn = "1999-4915",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "12",

}

TY - JOUR

T1 - Immunopathology of rsv

T2 - An updated review

AU - Bergeron, Harrison C.

AU - Tripp, Ralph A.

N1 - Funding Information: Funding: This research was funded by the Tripp laboratory, and supported by the Georgia Research Alliance (GRA). Publisher Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland.

PY - 2021/12

Y1 - 2021/12

N2 - RSV is a leading cause of respiratory tract disease in infants and the elderly. RSV has limited therapeutic interventions and no FDA-approved vaccine. Gaps in our understanding of virus–host interactions and immunity contribute to the lack of biological countermeasures. This review updates the current understanding of RSV immunity and immunopathology with a focus on interferon responses, animal modeling, and correlates of protection.

AB - RSV is a leading cause of respiratory tract disease in infants and the elderly. RSV has limited therapeutic interventions and no FDA-approved vaccine. Gaps in our understanding of virus–host interactions and immunity contribute to the lack of biological countermeasures. This review updates the current understanding of RSV immunity and immunopathology with a focus on interferon responses, animal modeling, and correlates of protection.

KW - Host–pathogen interaction

KW - Immunity

KW - Immunopathology

KW - Respiratory syncytial virus

KW - RSV

UR - http://www.scopus.com/inward/record.url?scp=85121427632&partnerID=8YFLogxK

U2 - 10.3390/v13122478

DO - 10.3390/v13122478

M3 - Review article

C2 - 34960746

AN - SCOPUS:85121427632

SN - 1999-4915

VL - 13

SP - 1

EP - 30

JO - Viruses

JF - Viruses

IS - 12

M1 - 2478

ER -

Immunopathology of rsv: An updated review

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this